Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-832-3 | CAS number: 872-85-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 17 February - 23 April 2003
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP - guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Isonicotinaldehyde
- EC Number:
- 212-832-3
- EC Name:
- Isonicotinaldehyde
- Cas Number:
- 872-85-5
- Molecular formula:
- C6H5NO
- IUPAC Name:
- pyridine-4-carbaldehyde
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report) : Pyridine-4-aldehyde
- Physical state : clear yellowish liquid
- Analytical purity : 98,7% (GC)
- Lot/batch No. : 1120126/001
- Storage condition of test material : Refrigerator at ca. 4°C , in the dark , under nitrogen
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaCruBR
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source : Charles River UK Limited , England CT9 4LT
- Age at study initiation : appr. 8 weeks
- Weight at study initiation : 18,2 - 23,4 g
- Housing : animals were housed singly in Makrolon cages type II (22cm x 16,5cm ground area , 15cm high) , Bedding material : wood chips
- Diet : Altromin maintenance diet for rats and mice , item No. 1324forte , germ reduction by 25 kGy 60Co-gamma irradiation , ad libitum
- Water : Tap water , offered in Makrolon-bottles with stainless steel canules , ad libitum
- Acclimation period : 8 days
ENVIRONMENTAL CONDITIONS
- Temperature : average of 22,0°C (continuous monitoring and recording)
- Humidity : average of 33,1% (continuous monitoring and recording)
- Air changes (per hr) : no data
- Photoperiod (hrs dark / hrs light) : 12/12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Group A (low dose) : 25% (v/v) solution of "Pyridine-4-aldehyde" in AOO
Group B (mid dose) : 50% (v/v) solution of "Pyridine-4-aldehyde" in AOO
Group C (high dose) : 100% (undiluted) "Pyridine-4-aldehyde"
AOO = acetone:olive oil , 4:1 (v/v) - No. of animals per dose:
- 5
- Details on study design:
- MAIN STUDY
- Criteria used to consider a positive response :
According to the guideline the decision process with regard to a positive response includes a stimulation index of equal to or greater than 3 .
The positive control substance led to a stimulation index of 13,4 , thus demonstrating the validity of the experiment .
TREATMENT PREPARATION AND ADMINISTRATION:
The test substance was diluted with acetone:olive oil , 4:1 (v/v) or undiluted and was administered to three groups of 5 female CBA/Ca mice . Administration was performed epicutaneously to the dorsal surface of both ears , once a day on 3 consecutive days . The volume administered was 25 µl per ear .
Concentrations used (AOO = acetone:olive oil , 4:1 (v/v)) :
-Group A (low dose) : 25% (v/v) solution of "Pyridine-4-aldehyde" in AOO
-Group B (mid dose) : 50% (v/v) solution of "Pyridine-4-aldehyde" in AOO
-Group C (high dose) : 100% (undiluted) "Pyridine-4-aldehyde"
Two groups with 5 animals each served as positive and negative controls . Both control substances were administered under identical conditions as the test substance .
The following solutions served as control substances :
-Group P (positive control) : 25% (v/v) solution of hexyl cinnamic aldehyde in AOO
-Group K (negative control) : AOO
5 days after the first topical administration , each animal received 20 µCi 3H-methyl thymidine (3H-TdR) by intravenous administration . The injection solution containing 80 µCi/ml 3H-TdR was prepared by the dilution of 720 µl 3H-TdR (amersham pharmacia biotech , Kat.Nr.:TRA 310 , batch 306 , specific activity 2.0 Ci/mmol , radioactive concentration 1 mCi/ml , radiochemical purity 99,3% , thymine content 0,1%) with 8,28 ml sterile phosphate buffered saline (PBS) . Then 250 µl of the solution were intravenously administered to each animal via a tail vein .
Approximately 5 hours after 3H-TdR injection all animals were sacrificed by carbon dioxide asphyxiation and the draining auricular lymph nodes were rapidly excised . The lymph nodes of each group were pooled in PBS : A single cell suspension (SCS) of lymph node cells (LNC) was prepared by gentle mechanical disaggregation of the pooled lymph nodes through a 70 µm cell strainer . The SCS were then transferred into centrifuge tubes and LNC were pelleted by centrifugation (4°C , max. 200 g , 10 min) : Afterwards supernatants were removed by aspiration . Then the LNC were resuspended and washed twice with PBS . After the final washing the supernatants were removed leaving just a small volume (<0,5ml) and macromolecules were precipitated by incubation with 5% trichloroacetic acid (TCA) at 4°Overnight . Each precipitate was pelleted by centrifugation (4°C , max. 200g , 10 min) and resuspended in 1 ml TCA . This suspension was transferred into scintillation vials containing 10 ml scintillation cocktail (Packard Bioscience : Ultima Gold , Bestellnr. 6013329) and 3H-TdR incorporation was determined with a beta-scintillation counter (TriCarb 2200CA , PackardInstrument Co. , protocol 4 : single label 3H , dpm , AEC-quenchcurve in Ultima Gold from21 June 2002) . - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- Statistical analysis of body mass differences between the groups on Days 1 and 6 was performed by the analysis of variance followed the Scheffe test (p=0,05 , two sided)
Statistical analysis of ear thickness differences between the groups was performed by the analysis of variance followed by the Scheffe test (p=0,05 , two sided) or by the H-Test when the conditions for the analysis of variance were not met .
Results are presented as test/control ratio (Stimulation index) , calculated as : dpm test group/dpm negative control group
(dpm = disintegrations per minute , corrected by the subtraction of the mean background)
A substance is regarded as a sensitiser in the LLNA if the test substance induces a 3-fold or greater increase in 3H-TdR incorporation into lymph node cells of test lymph nodes relative to that recorded for control lymph nodes , as indicated by the SI , together with the consideration of dose response .
Results and discussion
- Positive control results:
- Application of 25% hexyl cinnamic aldehyde in AOO resulted in an Stimulation index of 13,4 . This proves the sensitivity of the strain of animals used and the reliability of the experiment technique .
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: The Stimulation index of the test substance groups was between 11,5 and 12,9 . There was no concentration related response . For detailed information see "Any other information on results incl. tables"
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: For detailed information see "Any other information on results incl. tables"
Any other information on results incl. tables
dpm results and calculated stimulation indices (SIs)
dpm | SI | |
group K (negative control) | 1818 | 1 |
group A (low dose) | 23441 | 12,9 |
group B (mid dose) | 20976 | 11,5 |
group C (high dose) | 21516 | 11,8 |
group C (positive control) | 24494 | 13,5 |
Mortality : All animals survived till the end of the study .
General observations ;
No abnormal behaviour or clinical signs were detected during the experiment in the animals . All animals of the highest test substance group (C) showed white crystalline crusts on the auricles on day 4 , they were inconspicuous the other days .
Skin reactions :
No local irritations were observed at the application sites of all animals of all test substance groups and the negative control group throughout the whole study . On days 2, 3 and 4 all animals of the positive control group had moderate erythema on the application sites indicating slight irritative skin reactions .
Body mass :
There were no statistically significant differences in mean body masses between the dosed groups and the negative control on days 1 and 6 .
Ear thickness :
Some ears in the high dosed group were thicker than the ears in the control group , but because of a high scattering , the values did not gain statistical significance . There were no differences in mean ear thickness between the other substance groups and the negative control on day 4 . The ear thickness of the positive control group was significantly different to the negative control group on day 4 .
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (skin sensitising) based on GHS criteria
- Remarks:
- Migrated information
- Conclusions:
- The study was performed according to the OECD TG429 without deviations and according to the good laboratory practice principles, it is considered to be of highest quality (reliability Klimisch 1). The criteria of validity of the test system are fulfilled. Data from ear thickness measurements show that "Pyridine-4-aldehyde" is not a strong skin irritant . Therefore a false positive result induced by dermal irritation can be excluded .
Although no concentration related response was observed , "Pyridine-4-aldehyde" is regarded as a sensitiser in the LLNA according to the OECD-Guideline 429 , "Skin Sensitisation : Local Lymph Node Assay" , since the stimulation indices of all examined test substance concentrations were clearly greater than 3 . - Executive summary:
The Local Lymph Node Assay was performed to evaluate a possible skin sensitising potential of "Pyridine-4-aldehyde" according to the OECD-Guideline 429, "Skin Sensitisation: Local Lymph Node Assay". The test substance was used diluted with acetone:olive oil, 4:1 (v/v) or undiluted and was administered to three groups of 5 female CBA/Ca mice. Administration was performed epicutaneously to the dorsal surface of both ears, once a day on 3 consecutive days. The volume administered was 25 µL per ear.
Concentrations used (AOO= acetone:olive oil, 4:1 v/v).
Group A (low dose):
25% (v/v) solution of "Pyridine-4 -aldehyde" in AOO
Group B (mid dose):
50% (v/v) solution of "Pyridine-4-aldehyde" in AOO
Group C (high dose):
100% (undiluted) "Pyridine-4-aldehyde"
Two groups with 5 animals each served as positive and negative controls. Both control substances were administered under identical conditions as the test substance.
The following solutions served as control substances:
- Group P (positive control):25% (v/v)solution of hexyl cinnamic aldehyde in AOO
- Group K (negative control): AOO
5 days after the first topical application, 3H-methyl thymidine was intravenously administered to all mice via a tail vein. Approximately 5 hours later all animals were sacrificed, the draining auricular lymph nodes were excised, pooled for each group, and single cell suspensions were prepared. Then the incorporation of 3H-methyl thymidine into the cells was determined (liquid scintillation counter) and compared with the negative controls. The stimulation index (SI) was calculated as the ratio of the disintegrations per minute (dpm) of the dosed group or of the positive control group to the dpm of the negative control group. Ear thickness of all animals was measured before the first and 24 hours after the last administration to get an information about the skin irritating properties of the substances administered.
All animals survived till the end of the study. Moderate erythema was noted in all animals of the positive control group on Days 2-4, indicating slight local skin irritation. This slight irritating effect was confirmed by a statistically significant difference of the ear thickness between the positive control group and the negative control group on Day 4. No skin irritating effects were observed in the test substance groups and the negative control group throughout the whole study. There was no statistically significant difference in ear thickness between the test substance groups and the negative control group on Day 4.
3H-methyl thymidine incorporation, stimulation indices :
The calculated stimulation indices (test substance/negative control ratio) were decisive for the grading of the potential of sensitisation: According to the guideline the decision process with regard to a positive response includes a stimulation index of equal to or greater than 3, together with consideration of dose-response. The SI of each tested test substance group was clearly above the limit of "3". There was no concentration related response. The positive control substance led to a stimulation Index of 13.4, thus demonstrating the validity of the experiment.
According to the OECD-Guideline 429, "Skin Sensitisation: Local Lymph Node Assay", "Pyridine-4-aldehyde" is regarded as a sensitiser in the Local Lymph Node Assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.